ReviewCancer drug resistance (Alhambra, Calif.)2022

Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance.

Md Imtiaz Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.